Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Fojo

Showing results (91-100 of 180) with videos related to

Pageof 18
Sort By:
The Journal of Biological Chemistry|July 4, 1997
Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerizationP Giannakakou, D L Sackett, Y K Kang, et al.
Biochemical Pharmacology|December 1, 2001
Accompanying protein alterations in malignant cells with a microtubule-polymerizing drug-resistance phenotype and a primary resistance mechanismM S Poruchynsky, P Giannakakou, Y Ward, et al.
The Journal of Clinical Endocrinology and Metabolism|July 14, 1998
Effects of p53-expressing adenovirus on the chemosensitivity and differentiation of anaplastic thyroid cancer cellsM V Blagosklonny, P Giannakakou, M Wojtowicz, et al.
Nature Reviews. Cancer|April 13, 2018
Revisiting the role of ABC transporters in multidrug-resistant cancerRobert W Robey, Kristen M Pluchino, Matthew D Hall, et al.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2001
Low concentrations of the histone deacetylase inhibitor, depsipeptide (FR901228), increase expression of the Na(+)/I(-) symporter and iodine accumulation in poorly differentiated thyroid carcinoma cellsM Kitazono, R Robey, Z Zhan, et al.
Blood|December 24, 1998
Efflux of rhodamine from CD56+ cells as a surrogate marker for reversal of P-glycoprotein-mediated drug efflux by PSC 833R Robey, S Bakke, W Stein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
The P-glycoprotein antagonist PSC 833 increases the plasma concentrations of 6alpha-hydroxypaclitaxel, a major metabolite of paclitaxelM H Kang, W D Figg, Y Ando, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 25, 2021
The Effect of Buprenorphine on Human Immunodeficiency Virus Viral SuppressionJongyeon Kim, Catherine R Lesko, Anthony T Fojo, et al.
Cancer Treatment and Research|January 1, 1989
Mechanisms of resistance to cisplatin and alkylating agentsT C Hamilton, G M Lai, M L Rothenberg, et al.
Blood|May 15, 1997
Expression of the multidrug resistance-associated protein gene in refractory lymphoma: quantitation by a validated polymerase chain reaction assayZ Zhan, V A Sandor, E Gamelin, et al.
Pageof 18

Showing results (91-100 of 180) with videos related to

Sort By:
Pageof 18
The Journal of Biological Chemistry|July 4, 1997
Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerizationP Giannakakou, D L Sackett, Y K Kang, et al.
Biochemical Pharmacology|December 1, 2001
Accompanying protein alterations in malignant cells with a microtubule-polymerizing drug-resistance phenotype and a primary resistance mechanismM S Poruchynsky, P Giannakakou, Y Ward, et al.
The Journal of Clinical Endocrinology and Metabolism|July 14, 1998
Effects of p53-expressing adenovirus on the chemosensitivity and differentiation of anaplastic thyroid cancer cellsM V Blagosklonny, P Giannakakou, M Wojtowicz, et al.
Nature Reviews. Cancer|April 13, 2018
Revisiting the role of ABC transporters in multidrug-resistant cancerRobert W Robey, Kristen M Pluchino, Matthew D Hall, et al.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2001
Low concentrations of the histone deacetylase inhibitor, depsipeptide (FR901228), increase expression of the Na(+)/I(-) symporter and iodine accumulation in poorly differentiated thyroid carcinoma cellsM Kitazono, R Robey, Z Zhan, et al.
Blood|December 24, 1998
Efflux of rhodamine from CD56+ cells as a surrogate marker for reversal of P-glycoprotein-mediated drug efflux by PSC 833R Robey, S Bakke, W Stein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
The P-glycoprotein antagonist PSC 833 increases the plasma concentrations of 6alpha-hydroxypaclitaxel, a major metabolite of paclitaxelM H Kang, W D Figg, Y Ando, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 25, 2021
The Effect of Buprenorphine on Human Immunodeficiency Virus Viral SuppressionJongyeon Kim, Catherine R Lesko, Anthony T Fojo, et al.
Cancer Treatment and Research|January 1, 1989
Mechanisms of resistance to cisplatin and alkylating agentsT C Hamilton, G M Lai, M L Rothenberg, et al.
Blood|May 15, 1997
Expression of the multidrug resistance-associated protein gene in refractory lymphoma: quantitation by a validated polymerase chain reaction assayZ Zhan, V A Sandor, E Gamelin, et al.
Pageof 18